These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 23009112

  • 1. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
    Faria MH, Neves Filho EH, Alves MK, Burbano RM, de Moraes Filho MO, Rabenhorst SH.
    APMIS; 2012 Nov; 120(11):882-9. PubMed ID: 23009112
    [Abstract] [Full Text] [Related]

  • 2. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 3. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M, Peraud A, Leroch B, Kreth FW.
    Cancer; 2004 Sep 01; 101(5):1028-35. PubMed ID: 15329912
    [Abstract] [Full Text] [Related]

  • 4. TP53 codon 72 and intron 3 polymorphisms and mutational status in gastric cancer: an association with tumor onset and prognosis.
    Neves Filho EH, Cordeiro DE, Vieira AP, Rabenhorst SH.
    Pathobiology; 2012 Sep 01; 79(6):323-8. PubMed ID: 22688387
    [Abstract] [Full Text] [Related]

  • 5. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan 01; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 6. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 7. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar 15; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 8. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
    Parhar P, Ezer R, Shao Y, Allen JC, Miller DC, Newcomb EW.
    Brain Res Mol Brain Res; 2005 Jun 13; 137(1-2):98-103. PubMed ID: 15950766
    [Abstract] [Full Text] [Related]

  • 9. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr 13; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 10. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
    Jha P, Jha P, Pathak P, Chosdol K, Suri V, Sharma MC, Kumar G, Singh M, Mahapatra AK, Sarkar C.
    Exp Mol Pathol; 2011 Apr 13; 90(2):167-72. PubMed ID: 21115003
    [Abstract] [Full Text] [Related]

  • 11. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.
    van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG.
    J Natl Cancer Inst; 1994 Jul 06; 86(13):1011-7. PubMed ID: 8007011
    [Abstract] [Full Text] [Related]

  • 12. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S.
    Brain Tumor Pathol; 2010 Oct 06; 27(2):95-101. PubMed ID: 21046311
    [Abstract] [Full Text] [Related]

  • 13. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
    Idbaih A, Boisselier B, Marie Y, El Hallani S, Sanson M, Crinière E, Rodero M, Carpentier C, Paris S, Laigle-Donadey F, Ducray F, Hoang-Xuan K, Delattre JY.
    Cancer Genet Cytogenet; 2007 Sep 06; 177(2):103-7. PubMed ID: 17854663
    [Abstract] [Full Text] [Related]

  • 14. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
    Pollack IF, Hamilton RL, Finkelstein SD, Campbell JW, Martinez AJ, Sherwin RN, Bozik ME, Gollin SM.
    Cancer Res; 1997 Jan 15; 57(2):304-9. PubMed ID: 9000573
    [Abstract] [Full Text] [Related]

  • 15. Alterations of the TP53 gene in human gliomas.
    Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH.
    Cancer Res; 1994 Mar 01; 54(5):1324-30. PubMed ID: 8118823
    [Abstract] [Full Text] [Related]

  • 16. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M.
    J Neuropathol Exp Neurol; 2007 Oct 01; 66(10):944-54. PubMed ID: 17917588
    [Abstract] [Full Text] [Related]

  • 17. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
    Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P, Kaur B, Van Meir EG.
    Cancer Res; 2002 May 15; 62(10):2897-905. PubMed ID: 12019170
    [Abstract] [Full Text] [Related]

  • 18. Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.
    Thon N, Eigenbrod S, Grasbon-Frodl EM, Ruiter M, Mehrkens JH, Kreth S, Tonn JC, Kretzschmar HA, Kreth FW.
    J Neuropathol Exp Neurol; 2009 Nov 15; 68(11):1219-28. PubMed ID: 19816195
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.
    Antonelli M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F.
    J Neurooncol; 2010 Sep 15; 99(2):209-15. PubMed ID: 20174854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.